Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
Munteanu M, Tiniakos D, Anstee Q, Charlotte F, Marchesini G, Bugianesi E, Trauner M, Romero Gomez M, Oliveira C, Day C, Dufour JF, Bellentani S, Ngo Y, Traussnig S, Perazzo H, Deckmyn O, Bedossa P, Ratziu V, Poynard T; FLIP Consortium and the FibroFrance Group. Munteanu M, et al. Among authors: bedossa p. Aliment Pharmacol Ther. 2016 Oct;44(8):877-89. doi: 10.1111/apt.13770. Epub 2016 Aug 23. Aliment Pharmacol Ther. 2016. PMID: 27549244 Free PMC article.
Risk factors of fibrosis in alcohol-induced liver disease.
Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S. Raynard B, et al. Among authors: bedossa p. Hepatology. 2002 Mar;35(3):635-8. doi: 10.1053/jhep.2002.31782. Hepatology. 2002. PMID: 11870378
A comparison of fibrosis progression in chronic liver diseases.
Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P; PANFIBROSIS Group. Poynard T, et al. Among authors: bedossa p. J Hepatol. 2003 Mar;38(3):257-65. doi: 10.1016/s0168-8278(02)00413-0. J Hepatol. 2003. PMID: 12586290
Direct and indirect evidence for the reversibility of cirrhosis.
Serpaggi J, Carnot F, Nalpas B, Canioni D, Guéchot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S. Serpaggi J, et al. Among authors: bedossa p. Hum Pathol. 2006 Dec;37(12):1519-26. doi: 10.1016/j.humpath.2006.07.007. Epub 2006 Sep 25. Hum Pathol. 2006. PMID: 16997354
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
Zimmermann E, Anty R, Tordjman J, Verrijken A, Gual P, Tran A, Iannelli A, Gugenheim J, Bedossa P, Francque S, Le Marchand-Brustel Y, Clement K, Van Gaal L, Sørensen TIA, Jess T. Zimmermann E, et al. Among authors: bedossa p. J Hepatol. 2011 Sep;55(3):660-665. doi: 10.1016/j.jhep.2010.12.017. Epub 2011 Jan 14. J Hepatol. 2011. PMID: 21238518
Fighting the bushfire in HCC trials.
Schirmacher P, Bedossa P, Roskams T, Tiniakos DG, Brunt EM, Zucman-Rossi J, Manns MP, Galle PR. Schirmacher P, et al. Among authors: bedossa p. J Hepatol. 2011 Aug;55(2):276-7. doi: 10.1016/j.jhep.2011.03.004. Epub 2011 Mar 22. J Hepatol. 2011. PMID: 21439335 Free article. No abstract available.
508 results